Hong Kong stocks related to innovative drugs fell, with Hutchison MediPharma (00013.HK) falling more than 13%, Zai Lab (09688.HK) falling 10.7%, Lepu Biopharmaceuticals (02157.HK) and BeiGene (06160.HK) falling more than 5%, and Hengrui Medicine (01276.HK) falling more than 4%.

2025-08-08 09:53:27

BeiGene

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    After the financial report was released, AMD (AMD.O) rose 1.5% in after-hours trading.
                            2025-08-06

                                    AMD (AMD.O) revenue in Q2 2025 was US$7.685 billion, compared with market expectations of US$7.42 billion and US$5.8 billion in the same period last year.
                            2025-08-06

                                    AMD (AMD.O): Quarterly inventory and related expenses reached $800 million due to U.S. government export controls.
                            2025-08-06

                                    AMD (AMD.O): Expected third-quarter revenue of $8.7 billion.
                            2025-08-06

                                    The State-owned Assets Supervision and Administration Commission of the State Council released the first batch of strategic high-value scenarios of artificial intelligence for central enterprises
                            2025-08-05